
Rebody Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.6/10
Best for: Shoppers who want transparent, dose-based GLP-1 pricing with oral, injectable, or brand-name options
Rebody Health is a solid telehealth option with balanced features and pricing.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Rebody Health (rebodyhealth.com), operated by Compound Technologies Inc., is a transparent-pricing GLP-1 and wellness telehealth service that publishes prices up front. It offers compounded semaglutide and tirzepatide as weekly injections (from about $199.99 and $249.99/mo) and as daily oral 'melt' tablets, plus brand-name Wegovy and Zepbound, with dose-based pricing shown before each refill. Available in 47 states (not Massachusetts, Rhode Island, or Vermont). Rebody is not a pharmacy; prescriptions are prepared by licensed compounding pharmacies not named on the site.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Rebody Health
Direct Meds
Best for: listed for transparent disclosure — see FDA warning and BBB complaint pattern before considering
Editorial score · methodology
Maximus
Best for: men seeking compounded GLP-1 alongside testosterone optimization
Editorial score · methodology
Sesame Care
Best for: Brand-name GLP-1s (Wegovy, Zepbound) at LillyDirect/NovoCare cash prices — no compounding
Editorial score · methodology
Rebody Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199.99/mo (Weekly compounded injection from $199.99/mo, dose-scaled higher as the prescription increases; daily oral 'melt' semaglutide from $143.99/mo. $50 off first month.)
- Pricing model
- Scales with dose — higher doses cost more
- What's included
- Medication · Consult
- Availability
- 47 states
- FDA status
- No FDA warning letter on record
How we scored Rebody Health
Each dimension is scored algorithmically from Rebody Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.8/10At $199.99/mo, Rebody Health runs about 18% above the $170 median for GLP-1 providers. Note the price scales with dose, so budget for higher tiers as you titrate.
Effectiveness25%
8.5/10Rebody Health offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.4/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
8.1/10Key details fully confirmed by our editors; no FDA warning letters on file (last checked 2026-07-21).
Accessibility10%
8.3/10Rebody Health treats patients in all 50 states.
Support10%
5.9/10Rebody Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Rebody Health review
Last checked July 2026- Confirmed current pricing across 4 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
What to expect when you sign up with Rebody Health
We walked Rebody Health’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Browse the public pricing page to see dose-based prices before creating an account.
- 2Use the 'Find my treatment' flow and complete an online health visit.
- 3A licensed clinician reviews your information and, if appropriate, issues a prescription.
- 4The medication price for your dose and supply is confirmed before each shipment.
- Pricing is fully public on a dedicated pricing page, updated with a date, before any signup.
- Pricing is dose-scaled: the starting-dose price is shown, with higher tiers if the prescription increases.
- Compounded semaglutide and tirzepatide are offered as both weekly injections and daily oral 'melt' tablets.
- Brand-name Wegovy and Zepbound are available for patients who prefer FDA-approved products.
- A $50-off-first-month code is advertised; service is not available in MA, RI, or VT.
GLP-1 medications Rebody Health offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Weekly compounded injection from $199.99/mo, dose-scaled higher as the prescription increases; daily oral 'melt' semaglutide from $143.99/mo. $50 off first month.
Weekly compounded injection from $249.99/mo, dose-scaled higher as the prescription increases; daily oral 'melt' tirzepatide from $249.99/mo.
Brand Wegovy weekly pen from $420.99/mo; Wegovy oral tablets from $343.99/mo.
Brand Zepbound KwikPen from $573.99/mo.
Ready to get started?
Plans and promotions change often — check Rebody Health's current pricing and active discounts before you decide.
What we like
- Publishes transparent, dose-based pricing up front on a public pricing page, so you can see costs without signing up
- Offers compounded semaglutide and tirzepatide as both weekly injections and daily oral 'melt' tablets
- Also carries brand-name Wegovy and Zepbound for patients who want FDA-approved products
- Clear plan-term vs dose-tier structure; the refill price is shown before each shipment, plus $50 off the first month
- Names its operating company (Compound Technologies Inc.) and references LegitScript approval
Watch-outs
- Individual compounding pharmacies are not named on the marketing site
- Not available in Massachusetts, Rhode Island, or Vermont
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
- Dose-scaled pricing means the monthly cost can rise as your prescribed dose increases
Is Rebody Health worth it? Our verdict
Rebody Health positions itself around one thing: Shoppers who want transparent, dose-based GLP-1 pricing with oral, injectable, or brand-name options. It runs $199.99/month — a premium to the category, so the extras need to justify it. Its standout is a needle-free oral option, which very few providers offer.
Where Rebody Health tries to set itself apart is the extras: Brand-name GLP-1, Oral & injectable, and Transparent pricing.
How much Rebody Health actually costs
- Compounded semaglutide — $199.99/month
- Compounded tirzepatide — $249.99/month
- Brand-name semaglutide — $420.99/month
- Brand-name tirzepatide — $573.99/month
For context, the typical ongoing price across the GLP-1 providers we track is around $170/month, so Rebody Health's standing rate sits at the premium end.
For a direct comparison, Care Bare Rx runs semaglutide and tirzepatide from $199/month — worth pricing against Rebody Health before you commit.
Medications: what Rebody Health prescribes
Rebody Health prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two most-studied weight-loss molecules on the market today. Both routes are on the table: FDA-approved brand pens, or the cheaper compounded version that keeps the monthly cost down but isn't FDA-approved as a finished product.
Rebody Health's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used, so treat it as a convenience option rather than a proven equal to the shot.
Who Rebody Health is best for — and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option.
- live anywhere in the US and want guaranteed access.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like bmiMD will likely beat the ongoing price.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
Rebody Health treats patients in all 50 states. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Rebody Health costs more than the budget end of the market, so it makes the most sense if its specific extras — the oral option especially matter to you. If they don't, you can likely get the same medication for less elsewhere. If you're comparison-shopping, Maximus is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
Rebody Health is a solid telehealth option with balanced features and pricing.
Ready to start with Rebody Health?
Starting at $199.99/month. See current pricing and start your free consultation.
Rebody Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Found.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Rebody Health review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Rebody Health's current pricing
Plans start at $199.99/month. Start your free consultation to check eligibility and today's price.